Indian Navy Biovascular Scaffold and Vericiguat Tender 2026 – ISI/ GMP Standards Not Specified, Sample Option 25%
Bid Publish Date
01-Sep-2026, 10:36 am
Bid End Date
11-Sep-2026, 11:00 am
Location
Progress
Tender Overview
The Indian Navy, Department Of Military Affairs, invites bids for six items including BIOVASCULAR SCAFFOLD, TAB VERICIGUAT 2.5MG, TAB VERICIGUAT 5MG, SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY, CANGRELORE FOR INJECTION 50MG VIAL, and TYSHÅK BALLOON. While exact quantities and estimated value are not disclosed, the tender specifies a 25% quantity option and reserves rights to modify orders. Bidders should anticipate possible sampling during technical evaluation and ensure products retain 5/6th of the shelf life at dispatch.
- Organization: Indian Navy
- Location: India (nationwide)
- Product scope includes cardiovascular and imaging contrast agents and related devices
- Key differentiator: option to increase/decrease quantity by up to 25% and post-order delivery adjustments
- Unique requirement: potential sample submission during evaluation
Technical Specifications & Requirements
Given the data, no detailed technical specs are provided. Extracted elements include:
- Product/service names as listed in the tender title
- Self-life criterion: items must have 5/6th remaining shelf life at dispatch
- Delivery timeline: line item mentions delivery “within time line” with option period linked to delivery orders
- Sample possibility: bidders may be asked to provide samples during technical evaluation
- Option clause: Purchaser may adjust quantity by up to 25% during contract
- No explicit IS/ISO/ISM standards specified; bidders should verify compliance during bid
Terms, Conditions & Eligibility
- Delivery terms: as per option clause – 25% quantity flexibility at contract placement and during currency
- Shelf-life: items must show 5/6th self life remaining at delivery
- Samples: potential requirement to present product samples during evaluation
- Compliance: bidders must adhere to the extended delivery time calculations if options are exercised
- Other: no explicit EMD or GST/ PAN details specified; bidders should prepare standard tender documents
Key Specifications
-
Product/service names: BIOVASCULAR SCAFFOLD; TAB VERICIGUAT 2.5MG; TAB VERICIGUAT 5MG; SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY; CANGRELORE FOR INJECTION 50MG VIAL; TYSHAK BALLOON
-
Shelf-life requirement: 5/6th remaining at delivery
-
Delivery flexibility: up to 25% quantity increase/decrease during contract
-
Sample submission: possible during technical evaluation
-
Delivery timeline: defined by last delivery order date; minimum extended period calculations apply
Terms & Conditions
-
Option clause allows ±25% quantity changes at contract and during currency
-
Items must have 5/6th shelf-life remaining at dispatch
-
Samples may be requested during technical evaluation
Important Clauses
Delivery Terms
Quantity may be increased/decreased by up to 25% at contract placement and during currency; delivery period adjustments based on formula with minimum 30 days
Shelf Life
Items delivered must have 5/6th of their shelf life remaining at the time of dispatch
Samples
Vendor may be asked to furnish product samples during technical evaluation
Bidder Eligibility
-
Eligibility to supply pharmaceutical/medical devices and imaging agents
-
Ability to meet 5/6th shelf-life requirement at dispatch
-
Capability to deliver within timeline and handle quantity adjustments up to 25%
Tender Data
Bid Details
Quantity
1218
Category
BIOVASCULAR SCAFFOLD
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
RA Qualification Rule
H1-Highest Priced Bid Elimination
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
No
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Min. Avg. Annual Turnover
3
OEM Avg. Turnover
3
Past Performance
20 %
Experience Required
2 Year (s)
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
BIOVASCULAR SCAFFOLD , TAB VERICIGUAT 2.5MG , TAB VERICIGUAT 5MG , SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY , CANGRELORE FOR INJECTION 50MG VIAL , TYSHAK BALLOON
Advisory Bank
State Bank of India
ePBG Percentage
3%
ePBG Duration (Months)
12
Delivery Details
Max Delivery Days
30
Delivery Locations
1
Delivery Cities
Visakhapatnam
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | Visakhapatnam | Visakhapatnam | - | - | 6 | 30 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-9642421.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
6 Items Sign in to view GEM price trends Sign in for GEM prices
BIOVASCULAR SCAFFOLD
BIOVASCULAR SCAFFOLD
TAB VERICIGUAT 2.5MG
TAB VERICIGUAT 2.5MG
TAB VERICIGUAT 5MG
TAB VERICIGUAT 5MG
SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY
SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY
CANGRELORE FOR INJECTION 50MG VIAL
CANGRELORE FOR INJECTION 50MG VIAL
TYSHAK BALLOON
TYSHAK BALLOON
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | BIOVASCULAR SCAFFOLD | BIOVASCULAR SCAFFOLD | 6 | no | oic-echs | 30 | |
| 2 | TAB VERICIGUAT 2.5MG | TAB VERICIGUAT 2.5MG | 600 | no | oic-echs | 30 | |
| 3 | TAB VERICIGUAT 5MG | TAB VERICIGUAT 5MG | 600 | no | oic-echs | 30 | |
| 4 | SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY | SULPHUR HEXAFLURIDE POWDER AND SOLVENT FOR INJECTION CONTRAST SONOGRAPHY STUDY | 6 | no | oic-echs | 30 | |
| 5 | CANGRELORE FOR INJECTION 50MG VIAL | CANGRELORE FOR INJECTION 50MG VIAL | 3 | no | oic-echs | 30 | |
| 6 | TYSHAK BALLOON | TYSHAK BALLOON | 3 | no | oic-echs | 30 |
Categories
2
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Frequently Asked Questions
Key insights about ANDHRA PRADESH tender market
How to bid for Indian Navy medical device tender 2026 in India?
Bidders should complete their technical and financial bids, submit OEM authorizations if applicable, and provide GST and PAN details. Ensure items meet 5/6th shelf life at dispatch and be prepared for a possible 25% quantity adjustment. Include any required samples during evaluation if requested.
What documents are required for this Indian Navy tender in India 2026?
Prepare GST certificate, PAN card, company registration, experience certificates for similar medical devices, financial statements, EMD documentation if applicable, OEM authorization letters, and technical compliance certificates for the listed products. Also include any samples if requested during evaluation.
What are the key technical specs for Vericiguat tablets in this tender?
The tender lists VERICIGUAT 2.5MG and 5MG tablets but provides no explicit technical specs. Suppliers should confirm API strength, packaging, shelf life, and regulatory approvals during bid submission and be ready to demonstrate compliance with relevant medical device or pharmaceutical standards.
When is delivery expected after order placement in this tender?
Delivery period is governed by the option clause, with potential extensions. The minimum delivery timeline uses the formula: (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days unless the original period is longer. Ensure readiness for phased deliveries if required.
What is the shelf life requirement for items under this Indian Navy tender?
Items must have 5/6th remaining shelf life at the time of dispatch. Suppliers should verify batch expiry dates and maintain traceability, ensuring that shipments reach the consignee before significant degradation risks occur.
Are samples required for evaluation in this medical tender by Indian Navy?
Yes, bidders may be asked to provide product samples during technical evaluation. Be prepared to furnish representative samples of BIOVASCULAR SCAFFOLD, VERICIGUAT tablets, and related items, accompanied by test reports or regulatory approvals as applicable.
What is the 25% option clause significance for this procurement?
The purchaser can increase or decrease awarded quantities by up to 25% at contract placement and during the currency, with adjusted delivery timelines. Bidders should price accordingly and plan for possible scale-up or scale-down without changing contract rates.
What is required for sample submission in technical evaluation for this tender?
If samples are requested, suppliers must provide authentic product samples for each listed item with proper labeling, batch numbers, and accompanying regulatory or quality documentation to verify conformity with stated product names.